KRAS and neoplasm: The nuclear enrichment of SOD1 is crucial for the proliferation of NSCLC cells, a fact corroborated by SOD1 inducible knockout studies in KRAS‐driven NSCLC mouse models, which significantly diminished the tumor burden in both in vivo and in vitro settings [33].